Aclarion, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
ACON Nasdaq 3840 www.aclarion.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aclarion, Inc.

Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site - Aug 20th, 2026 5:00 am
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process - Aug 12th, 2026 5:00 am
Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates - Aug 6th, 2026 10:00 am
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology - Aug 4th, 2026 5:00 am
Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026 - Jul 29th, 2026 5:00 am
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice - Jul 21st, 2026 5:00 am
Aclarion Announces Texas Spine Care Center as New CLARITY Site - Jul 7th, 2026 5:00 am
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub - Jun 10th, 2026 5:00 am
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform - Jun 9th, 2026 5:00 am
Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal - Jun 8th, 2026 5:05 am
Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting - Jun 8th, 2026 5:00 am
Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation - Jun 3rd, 2026 4:00 am
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study - Jun 1st, 2026 4:00 am
Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal - May 28th, 2026 12:49 pm
Echo Lake Capital Offers To Acquire Aclarion Inc. - May 28th, 2026 6:00 am
Aclarion (ACON) Upgraded to Buy: Here's Why - May 19th, 2026 10:00 am
Aclarion, Inc. (ACON) Reports Q1 Loss, Misses Revenue Estimates - May 13th, 2026 4:10 pm
Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates - May 7th, 2026 5:05 pm
Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment - May 7th, 2026 4:00 am
Aclarion Announces Inducement Grant to New Commercial Director, Western U.S. - May 6th, 2026 4:00 am